Percutaneous Cryoablation Peripheral Lung Cancer

Percutaneous Cryoablation for the Treatment of Medically Inoperable Peripheral Lung Cancer

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02665390

Acronym

PCPLC

Enrollment

Registered

2016-01-27

Start date

2016-02-29

Completion date

2020-01-31

Last updated

2016-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

lung cancer, Percutaneous cryoablation, treatment of medically inoperable

Brief summary

This study is focus on percutaneous cryoablation,which was for the treatment of medically inoperable Peripheral lung cancer.The patients who were agreed to attend the study will accept the operation. After the operations,they will follow up according to the plan.

Detailed description

The patients who were agreed to attend the study conclude early stage lung cancer and solitary metastatic lung cancer.

Interventions

PROCEDUREPercutaneous cryoablation

Percutaneous cryoablation

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

medically inoperable peripheral lung cancer Diameter no more than 3cm

Exclusion criteria

1. Refusal of participation 2. tendency to bleed to that can't receive percutaneous cryoablation. 3. Severe cardiopulmonary dysfunction and other indications that can't receive percutaneous cryoablation.

Design outcomes

Primary

Measure	Time frame
PFS	2 years

Secondary

Measure	Time frame
OS	2 years

Contacts

Primary ContactSun jiayuan, MD

18017321598

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026